Driehaus Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History

Driehaus Capital Management’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-16,539	Closed	-$897K	–	588
2018 Q1	$897K	Sell	16,539 -59,456	-78%	-$3.33M	0.03%	355
2017 Q4	$4.54M	Sell	75,995 -21,523	-22%	-$1.31M	0.17%	163
2017 Q3	$4.74M	Sell	97,518 -2,767	-3%	-$151K	0.18%	150
2017 Q2	$5.27M	Buy	+100,285	New	+$4.67M	0.19%	120
2015 Q2	–	Sell	-103,722	Closed	-$3.25M	–	603
2015 Q1	$3.25M	Sell	103,722 -2,837	-3%	-$82.2K	0.11%	231
2014 Q4	$3.11M	Buy	+106,559	New	+$2.7M	0.13%	221

Other funds holding AERI

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

FCMI

Foresite Capital Management II Larkspur, California $29.2M AUM 44.84% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Driehaus Capital Management's AERI Position: Q2 2018 in Review

Driehaus Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2018, closing a stake of 16,539 shares — an estimated $897K sold.

Driehaus Capital Management first reported a position in AERI in Q4 2014 and held it in 6 quarters. The position peaked at $5.27M in Q2 2017. 175 funds tracked by Wall St. Rank hold AERI as of Q2 2018.

Driehaus Capital Management reported no remaining Aerie Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
Driehaus Capital Management sold 16,539 Aerie Pharmaceuticals shares in Q2 2018, an estimated $897K.
Driehaus Capital Management first reported a position in Aerie Pharmaceuticals in Q4 2014 and held it in 6 quarters.
Driehaus Capital Management's Aerie Pharmaceuticals position peaked at $5.27M in Q2 2017.
175 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2018.

Based on Driehaus Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.